My major strength are drug discovery industrial experience in preclinical research learning and developing of in vitro, in vivo , cellular assay systems for diseases. Perform compound screening and subsequent evaluation of the inhibitory effect using animal models and molecular target. Have two international publication from peer reviewed journal like International Immunopharmacology (Impact factor 2.21) and European Journal of Pharmacology (Impact factor 2.51).
Specialties: Pre-clinical and clinical
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
